Why pathology testing is soon to cross new clinical boundaries

Abstract

Genetic medicine is poised to revolutionise healthcare. No medical specialty field will be more transformed by the use of genetic technology and genetic knowledge than pathology and laboratory medicine. To help pathologists and laboratory professionals understand the strategic implications of these developments, this presentation will provide an overview of how health system dynamics, financial considerations, and advances in genetic technology will drive forward the clinical acceptance and use of molecular technologies in pathology testing services. Themes to be discussed include how new genetic technologies will be incorporated into diagnostic testing services, market adoption paths for personalised medicine and companion diagnostics, and the role of laboratory informatics in linking laboratories with referring clinicians. Opportunities for pathology to participate as a collaborative diagnostic service will be identified. Pathologists will gain a strategic understanding of the major trends in healthcare and how these trends will support advancements in molecular diagnostics. Information and concepts presented will complement the presentations which follow during this session. Genetic medicine is poised to revolutionise healthcare. No medical specialty field will be more transformed by the use of genetic technology and genetic knowledge than pathology and laboratory medicine. To help pathologists and laboratory professionals understand the strategic implications of these developments, this presentation will provide an overview of how health system dynamics, financial considerations, and advances in genetic technology will drive forward the clinical acceptance and use of molecular technologies in pathology testing services. Themes to be discussed include how new genetic technologies will be incorporated into diagnostic testing services, market adoption paths for personalised medicine and companion diagnostics, and the role of laboratory informatics in linking laboratories with referring clinicians. Opportunities for pathology to participate as a collaborative diagnostic service will be identified. Pathologists will gain a strategic understanding of the major trends in healthcare and how these trends will support advancements in molecular diagnostics. Information and concepts presented will complement the presentations which follow during this session.